Research Antibodies Market Size (2024 - 2029)

The research antibodies market is projected to experience growth due to rising investments in research and development, the expansion of research academies, and increased collaborations within the industry. This market expansion is driven by the essential role of research antibodies in biopharmaceutical and pharmaceutical research, particularly in understanding biological processes and disease mechanisms. The growth is further supported by advancements in stem cell and neurobiology research, alongside product innovations and collaborations. Additionally, the increasing prevalence of neurodegenerative diseases and the demand for high-quality antibodies for neurobiology research, as well as the rising need for protein therapeutics and personalized medicine, are key factors contributing to the market's expansion.

Home Market Analysis Healthcare Research Biotechnology Research Biopharma Research Monoclonal Antibodies Research Research Antibodies Industry Market Size

Market Size of Research Antibodies Industry

Research Antibodies Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 5.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Research Antibodies Market Key Players

*Disclaimer: Major Players sorted in no particular order

Research Antibodies Market Analysis

The Research Antibodies Market is expected to register a CAGR of 5.5% during the forecast period. This is attributing to increasing investment in R&D, increasing research academies and industry collaborations, and a rise in proteomics and genomics research. As research antibodies are the essential component of biopharmaceutical and pharmaceutical research for the investigation of biological processes and to know the causes of diseases these antibodies play an important role. Thus, growing stem cells and neurobiology research around the globe with several product innovations and collaboration by the companies is fueling the growth of the market. For instance, in February 2019, a company ImmunoPrecise Antibodies LTD Collaborated with Foundation of Innovative New Diagnostic (FIND) to announce research collaboration project results in which they developed rabbit monoclonal antibodies using B cells select that helps in recognizing lipoarabinomannan (LAM) and biomarker for TB. Moreover, increasing incidences of neurodegenerative diseases such as multiple sclerosis and Parkinson's diseases leading to high demand of high-quality antibodies for neurobiology research and increasing demand of protein therapeutics, personalized medicines and development of novel drug is also some more factors that are anticipated to promote the research antibodies market in forecasted period.

Research Antibodies Industry Segmentation

As per the scope, Antibodies also referred to as immunoglobulin are glycoproteins, made up of B cells are a part of the human immune system. These antibodies can bind themselves to specific molecules which is an important property needed in science research also a very important tool to study the function of proteins in cells. Research Antibodies Market is segmented By Type, Source, Product, Application and Geography.

By Type
Monoclonal Antibodies
Polyclonal Antibodies
By Source
Rabbit
Mouse
Goat
Others
By Product
Primary
Secondary
By Application
Immunology
Infectious Diseases
Stem Cells
Oncology
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Research Antibodies Market Size Summary

The Research Antibodies Market is poised for steady growth, driven by increasing investments in research and development, expanding collaborations between research academies and industries, and a surge in proteomics and genomics studies. Research antibodies are crucial in biopharmaceutical and pharmaceutical research, aiding in the exploration of biological processes and disease causation. The market is further bolstered by advancements in stem cell and neurobiology research, alongside product innovations and strategic collaborations. The demand for high-quality antibodies is particularly rising due to the growing prevalence of neurodegenerative diseases and the increasing focus on protein therapeutics, personalized medicine, and novel drug development. Primary antibodies, known for their specificity and ease of use, are gaining traction in various applications, including ELISA, flow cytometry, and western blotting, thereby driving segment growth.

North America is anticipated to maintain a significant share of the global Research Antibodies Market, attributed to the rising incidence of cardiovascular and blood diseases, which intensifies the focus on cancer research. The region benefits from substantial R&D expenditure, a robust presence of pharmaceutical and biopharmaceutical companies, and advanced research infrastructure. The market is moderately competitive, with key players such as Bio-Rad Laboratories, Abcam plc, Merck KGaA, and Thermo Fisher Scientific leading the charge. These companies are instrumental in shaping the market landscape through their innovative offerings and strategic initiatives, ensuring continued growth and development in the research antibodies sector.

Explore More

Research Antibodies Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Investment In R&D

      2. 1.2.2 Increase In Research Academies And Industry Collaborations

      3. 1.2.3 Rise In Proteomics And Genomics Research

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost Of Research Antibodies

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Type

      1. 2.1.1 Monoclonal Antibodies

      2. 2.1.2 Polyclonal Antibodies

    2. 2.2 By Source

      1. 2.2.1 Rabbit

      2. 2.2.2 Mouse

      3. 2.2.3 Goat

      4. 2.2.4 Others

    3. 2.3 By Product

      1. 2.3.1 Primary

      2. 2.3.2 Secondary

    4. 2.4 By Application

      1. 2.4.1 Immunology

      2. 2.4.2 Infectious Diseases

      3. 2.4.3 Stem Cells

      4. 2.4.4 Oncology

      5. 2.4.5 Others

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle-East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle-East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Research Antibodies Market Size FAQs

The Research Antibodies Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)

Bio-Rad Laboratories, Inc. , Abcam plc, Merck KGaA, Thermo Fisher Scientific and Becton, Dickinson and Company are the major companies operating in the Research Antibodies Market.

Research Antibodies Market Report Snapshots

Research Antibodies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)